CCM
CC icon

Cadence Capital Management’s Chemours CC Stock Holding History

Cadence Capital Management’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-17,994
Closed -$710K – 473
2018
Q3 		$710K Buy
+17,994
New +$787K 0.04% 449

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Cadence Capital Management's CC Position: Q4 2018 in Review

Cadence Capital Management sold out of Chemours (CC) in Q4 2018, closing a stake of 17,994 shares — an estimated $710K sold.

Cadence Capital Management first reported a position in CC in Q3 2018 and held it in 1 quarter. The position peaked at $710K in Q3 2018. 506 funds tracked by Wall St. Rank hold CC as of Q4 2018.

  • Cadence Capital Management reported no remaining Chemours position as of Q4 2018 after selling out during the quarter.
  • Cadence Capital Management sold 17,994 Chemours shares in Q4 2018, an estimated $710K.
  • Cadence Capital Management first reported a position in Chemours in Q3 2018 and held it in 1 quarter.
  • Cadence Capital Management's Chemours position peaked at $710K in Q3 2018.
  • 506 funds tracked by Wall St. Rank held Chemours as of Q4 2018.

Based on Cadence Capital Management's 13F filing for Q4 2018, filed 13 Feb 2019.